Corvex enters at — the — market share sales agreement with Chardan Capital Markets
Corvex entered an at-the-market sales agreement with Chardan Capital Markets on October 14, 2026, to sell common stock from time to time. Chardan will receive a commission of 2.5% of aggregate gross proceeds. Net proceeds are intended for working capital and general corporate purposes. The company has no obligation to